Search

Search Constraints

You searched for: Author/Creator Tsuboi, Masahiro

Search Results

41. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung. (October 2016)

42. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung. (October 2016)

45. Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden. (December 2019)

46. Organoid culture containing cancer cells and stromal cells reveals that podoplanin-positive cancer-associated fibroblasts enhance proliferation of lung cancer cells. (August 2019)

47. Overall Survival Results of the Feasibility Study of Adjuvant Chemotherapy With Docetaxel Plus Cisplatin Followed by Long-term Single-agent Administration of S-1 in Patients With Completely Resected Non–Small Cell Lung Cancer: Thoracic Oncology Research Group (TORG) 0809. (November 2018)

49. P4‐111: COMPARISON OF DIAGNOSTIC ACCURACY OF AD AT PATIENTS' FIRST CONTACT BETWEEN VISUAL ASSESSMENT AND AUTOMATED ANALYSIS OF BRAIN PERFUSION SPECT. (1st July 2014)

50. Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial. Issue 10 (October 2022)